The Borlaug Report #8: Repligen

Trust the (Bio) Process

Introduction 

I felt weird writing about Avantor a few months ago. It was a name I knew well from following it for several years, but it felt phony to write a piece covering the business and why I didn’t own it. As such, while I’m sure I’ll write on names I don’t own again in the future, I’ve been waiting to write about Repligen until I’d gotten long mys…